These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10806406)

  • 1. Probing ligand-induced conformational changes of human CD38.
    Berthelier V; Laboureau J; Boulla G; Schuber F; Deterre P
    Eur J Biochem; 2000 May; 267(10):3056-64. PubMed ID: 10806406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and functional expression of bovine spleen ecto-NAD+ glycohydrolase: structural identity with human CD38.
    Augustin A; Muller-Steffner H; Schuber F
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):43-52. PubMed ID: 10600637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen.
    Inageda K; Takahashi K; Tokita K; Nishina H; Kanaho Y; Kukimoto I; Kontani K; Hoshino S; Katada T
    J Biochem; 1995 Jan; 117(1):125-31. PubMed ID: 7775378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of ADP-ribosyl cyclase activity of the cell surface antigen CD38 by zinc ions resulting from inhibition of its NAD+ glycohydrolase activity.
    Kukimoto I; Hoshino S; Kontani K; Inageda K; Nishina H; Takahashi K; Katada T
    Eur J Biochem; 1996 Jul; 239(1):177-82. PubMed ID: 8706705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of bovine spleen CD38/NAD+glycohydrolase disulfide-linked dimers.
    Berruet L; Muller-Steffner H; Schuber F
    Biochem Mol Biol Int; 1998 Nov; 46(4):847-55. PubMed ID: 9844746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.
    Cakir-Kiefer C; Muller-Steffner H; Oppenheimer N; Schuber F
    Biochem J; 2001 Sep; 358(Pt 2):399-406. PubMed ID: 11513738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD38 is an authentic NAD(P)+ glycohydrolase.
    Berthelier V; Tixier JM; Muller-Steffner H; Schuber F; Deterre P
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1383-90. PubMed ID: 9494110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the enzymatic active site of CD38 by site-directed mutagenesis.
    Munshi C; Aarhus R; Graeff R; Walseth TF; Levitt D; Lee HC
    J Biol Chem; 2000 Jul; 275(28):21566-71. PubMed ID: 10781610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction via the CD38/NAD+ glycohydrolase.
    Kontani K; Kukimoto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Nishina H; Takahashi K; Hazeki O; Katada T
    Adv Exp Med Biol; 1997; 419():421-30. PubMed ID: 9193684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities.
    Yamamoto-Katayama S; Ariyoshi M; Ishihara K; Hirano T; Jingami H; Morikawa K
    J Mol Biol; 2002 Feb; 316(3):711-23. PubMed ID: 11866528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorometric studies of ligand-induced conformational changes of CD38.
    Lacapère JJ; Boulla G; Lund FE; Primack J; Oppenheimer N; Schuber F; Deterre P
    Biochim Biophys Acta; 2003 Nov; 1652(1):17-26. PubMed ID: 14580993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.
    Cakir-Kiefer C; Muller-Steffner H; Schuber F
    Biochem J; 2000 Jul; 349(Pt 1):203-10. PubMed ID: 10861229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries.
    Sauve AA; Munshi C; Lee HC; Schramm VL
    Biochemistry; 1998 Sep; 37(38):13239-49. PubMed ID: 9748331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38.
    Kontani K; Nishina H; Ohoka Y; Takahashi K; Katada T
    J Biol Chem; 1993 Aug; 268(23):16895-8. PubMed ID: 8394323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities.
    Graeff R; Munshi C; Aarhus R; Johns M; Lee HC
    J Biol Chem; 2001 Apr; 276(15):12169-73. PubMed ID: 11278881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NAD+ glycohydrolase and ADP-ribosyl cyclase activities of leukocyte cell surface antigen CD38 by gangliosides.
    Hara-Yokoyama M; Kukimoto I; Nishina H; Kontani K; Hirabayashi Y; Irie F; Sugiya H; Furuyama S; Katada T
    J Biol Chem; 1996 May; 271(22):12951-5. PubMed ID: 8662799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
    Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
    J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic functions and structures of CD38 and homologs.
    Lee HC
    Chem Immunol; 2000; 75():39-59. PubMed ID: 10851778
    [No Abstract]   [Full Text] [Related]  

  • 19. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
    Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
    FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inhibitors of CD38: a mammalian cyclic ADP-ribose synthetase.
    Sauve AA; Schramm VL
    Biochemistry; 2002 Jul; 41(26):8455-63. PubMed ID: 12081495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.